WASHINGTON, July 16, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Report which conveys the depth and scope of Danaher’s sustainability program and highlights important milestones the Company achieved during the past year. “At the heart of everything we do... Read more
ApaVital S.A. to Optimize 4,000 Kilometers of Pipeline to Protect Water Supply for 500,000 People in Iasi WASHINGTON –(BUSINESS WIRE)–Jul. 16, 2024– A Romanian water utility is using advanced analytics to transform its infrastructure and tackle water losses in real time. ApaVital S.A. Read more
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, August 7, 2024, at 4:30 pm Eastern Time. The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/. Date:... Read more
ANDOVER, Mass., July 15, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release second quarter 2024 financial results after market close on Wednesday, August 7, 2024. Read more
myeloMATCH Precision Medicine Clinical Trial Leverages Next-Day Genomic Testing to Quickly Match Patients with Appropriate Trials Across North America WALTHAM, Mass.–(BUSINESS WIRE)– To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is partnering with the National... Read more
Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and microscopy expected to lead to better understanding of tumor structures and treatment strategies. New technology... Read more
Xylem’s Venture Investing Strategy Targets Direct Investments in Innovative Startups and Leading Venture Capital Partners WASHINGTON –(BUSINESS WIRE)–Jul. 10, 2024– Global water technology leader Xylem (NYSE: XYL) is expanding its corporate venture investing plans with $50 million committed to Read more
Subsequent Offering Period Scheduled to Expire at 5:00 p.m., New York Time, on July 16, 2024 WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics... Read more
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024 WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2024 before the market opens on Wednesday, July 24, 2024, and will hold a conference... Read more
The Avance® 1.2 GHz NMR system will enable advanced studies of biomolecular structures and function in structural biology, pharmacology, and cellular biology BERLIN–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, accepted in the second... Read more